ELISA TGFBR2 Antibody, HRP

Quantity :50µg Clone Number: Aliases:AAT3 antibody; FAA3 antibody; LDS1B antibody; LDS2 antibody; LDS2B antibody; MFS2 antibody; RIIC antibody; TAAD2 antibody; TbetaR II antibody; TbetaR-II antibody; TGF beta receptor type 2 antibody; TGF beta receptor type II antibody; TGF beta receptor type IIB antibody; TGF beta type II receptor antibody; TGF-beta receptor type II antibody; TGF-beta receptor type-2 antibody; TGF-beta type II receptor antibody; TGF-beta-R2 antibody; TGFB R2 antibody; TGFbeta - RII antibody; TGFbeta RII antibody; Tgfbr2 antibody; TGFR-2 antibody; TGFR2_ antibody; Transforming growth factor beta receptor II antibody; Transforming growth factor beta receptor type II antibody; Transforming growth factor beta receptor type IIC antibody; Transforming growth factor, beta receptor II (70/80kDa) antibody; transforming growth factor, beta receptor II alpha antibody; transforming growth factor, beta receptor II beta antibody; transforming growth factor, beta receptor II delta antibody; transforming growth factor, beta receptor II epsilon antibody; transforming growth factor, beta receptor II gamma antibody; Transforming growth factor-beta receptor type II antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:P37173 Immunogen:Recombinant TGF-beta receptor type-2 protein (25-159AA) Raised in:Rabbit Reactivity: Tested Applications:ELISA Background:Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regµLating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellµLar matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecµLes symmetrically bound to the cytokine dimer resµLts in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modµLates the transcription of the TGF-beta-regµLated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. Clonality:Polyclonal Isotype:IgG Purification Method:>95%, Protein G purified Conjµgate:HRP Buffer:Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:TGFBR2 Research Areas:Signal transduction; Stem cells